Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/29607
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMaes, Evelyne-
dc.contributor.authorOeyen, Eline-
dc.contributor.authorBoonen, Kurt-
dc.contributor.authorSchildermans, Karin-
dc.contributor.authorMertens, Inge-
dc.contributor.authorPauwels, Patrick-
dc.contributor.authorVALKENBORG, Dirk-
dc.contributor.authorBaggerman, Geert-
dc.date.accessioned2019-09-30T12:56:01Z-
dc.date.available2019-09-30T12:56:01Z-
dc.date.issued2019-
dc.identifier.citationMASS SPECTROMETRY REVIEWS, 38(3), p. 253-264-
dc.identifier.issn0277-7037-
dc.identifier.urihttp://hdl.handle.net/1942/29607-
dc.description.abstractNaturally occurring peptides, including growth factors, hormones, and neurotransmitters, represent an important class of biomolecules and have crucial roles in human physiology. The study of these peptides in clinical samples is therefore as relevant as ever. Compared to more routine proteomics applications in clinical research, peptidomics research questions are more challenging and have special requirements with regard to sample handling, experimental design, and bioinformatics. In this review, we describe the issues that confront peptidomics in a clinical context. After these hurdles are (partially) overcome, peptidomics will be ready for a successful translation into medical practice.-
dc.language.isoen-
dc.publisherWILEY-
dc.rights2018 by Wiley Periodicals, Inc.-
dc.subject.otherpeptidomics; biofluids; mass spectrometry; extraction; identification; neuropeptide-
dc.subject.otherpeptidomics; biofluids; mass spectrometry; extrac-tion; identification; neuropeptide-
dc.titleThe challenges of peptidomics in complementing proteomics in a clinical context-
dc.typeJournal Contribution-
dc.identifier.epage264-
dc.identifier.issue3-
dc.identifier.spage253-
dc.identifier.volume38-
local.format.pages12-
local.bibliographicCitation.jcatA1-
dc.description.notes[Maes, Evelyne; Oeyen, Eline; Boonen, Kurt; Schildermans, Karin; Mertens, Inge; Valkenborg, Dirk; Baggerman, Geert] Flemish Inst Technol Res VITO, Mol, Belgium. [Maes, Evelyne; Oeyen, Eline; Boonen, Kurt; Schildermans, Karin; Mertens, Inge; Valkenborg, Dirk; Baggerman, Geert] Univ Antwerp, Ctr Prote, Antwerp, Belgium. [Maes, Evelyne] AgResearch Ltd, Food & Biobased Prod, Lincoln, New Zealand. [Pauwels, Patrick] Antwerp Univ Hosp, Dept Pathol, Mol Pathol Unit, Edegem, Belgium. [Valkenborg, Dirk] Hasselt Univ, Ctr Stat, Diepenbeek, Belgium.-
local.publisher.placeHOBOKEN-
local.type.refereedRefereed-
local.type.specifiedReview-
dc.identifier.doi10.1002/mas.21581-
dc.identifier.isi000471702600003-
item.fullcitationMaes, Evelyne; Oeyen, Eline; Boonen, Kurt; Schildermans, Karin; Mertens, Inge; Pauwels, Patrick; VALKENBORG, Dirk & Baggerman, Geert (2019) The challenges of peptidomics in complementing proteomics in a clinical context. In: MASS SPECTROMETRY REVIEWS, 38(3), p. 253-264.-
item.fulltextWith Fulltext-
item.accessRightsRestricted Access-
item.contributorMaes, Evelyne-
item.contributorOeyen, Eline-
item.contributorBoonen, Kurt-
item.contributorSchildermans, Karin-
item.contributorMertens, Inge-
item.contributorPauwels, Patrick-
item.contributorVALKENBORG, Dirk-
item.contributorBaggerman, Geert-
item.validationecoom 2020-
crisitem.journal.issn0277-7037-
crisitem.journal.eissn1098-2787-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
maes 1.pdf
  Restricted Access		Published version323.43 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.